BRCA2 and neoplasm: Importantly, we provide evidence that a defect in USP21-mediated BRCA2 stabilization impairs the growth of BRCA2-proficient HCC tumor cells, and consistent with this, USP21 levels inversely correlate with HCC patient survival, pointing to USP21 as a potential target for HCC tumor therapy.